High Prevalence of Eye Diseases and Approval and Launch of New Products to Augment Growth of Pediatric Vitrectomy Market
High prevalence of eye diseases such as endophthalmitis, retinal detachments, and vitreous hemorrhage is expected to propel growth of the pediatric vitrectomy market. For instance, according to the study, ‘Increasing frequency of hospital admissions for retinal detachment and vitreo-retinal surgery in England 2000-2018’, published in November 2020, episodes of “retinal detachments with breaks” increased year on year from 3,447 in 2000 to 10,971 in 2018, whereas records of “tractional retinal detachment” increased from 290 to 910 in the same period.
However,
low presence of ophthalmologists in emerging economies is expected hinder
growth of the pediatric vitrectomy market. For instance, according to the
study, “Estimated number of ophthalmologists worldwide (International Council
of Ophthalmology update): will we meet the needs?” published in March 2020, in
2015, the ratio of ophthalmologists per million population for low-income
countries was 3.7 compared to 76.2 for high-income countries.
Asia Pacific is
expected to witness significant growth in the pediatric
vitrectomy market, owing to increasing prevalence of cataract in
the region. For instance, according to the study, “The prevalence and risk
factors for cataract in rural and urban India”, published in the Indian Journal
of Ophthalmology, in March 2019, cataract was present in 1094 of the rural and
649 subjects in the urban population and monotype subtype cataracts were found
in 32% and 25% in rural and urban population and 12.68% and 18.6% were mixed
cataracts in the rural and urban groups.
Competitive
Analysis
Major
players operating in the global pediatric vitrectomy market include, Bausch +
Lomb, Carl Zeiss Meditec AG, Optos Plc, Alcon, Orion Medic, Lumenis Ltd.,
Synergetics USA, Inc., Medone Surgical, Inc., Peregrine Surgical Ltd, and Nidek
Co. Ltd.
Major
players operating in the global pediatric vitrectomy market are focused on
approval and launch of new products to expand their product portfolio. For
instance, in January 2018, Bausch & Lomb and wholly owned subsidiary of
Valeant, received CE Mark from the European Commission for the Stellaris Elite
Vision Enhancement System, the company's next generation ophthalmic surgical
platform.
Major
players operating in the global pediatric vitrectomy market are also focused on
adopting various marketing strategies to enhance their market share. For
instance, in July 2020, Alcon announced to present key data highlighting
advancements in vitreoretinal surgery during the American Society of Retina
Specialists (ASRS) 2020 virtual annual meeting.
Comments
Post a Comment